- Applications, Inquiries and Nominations
- Search Committee
- Search Firm
- The Opportunity
- Message from the Search Committee Chair
- About UNMC
- UNMC Website
- 2011-2012 Accomplishments
- Campus Strategic Plan
- 2020 Health System Planning
- Clinical Partners
- Facilities Plan
- Fact Book
- Quality Indicators
- UNMC Organization Chart
News & Media
Dr. Robert Califf, vice chancellor for clinical research and director of the Duke Translational Medicine Institute (DTMI) at the Duke University Medical Center
Campus Visit: July 8-10
Public Presentation: 4 p.m., July 9, Room 1002 of the Durham Research Center
Califf leads a multifaceted organization focused on the transformation of how discoveries are translated into improved health outcomes. Prior to his role at DTMI, he was the founding director of the Duke Clinical Research Institute (DCRI), a premier academic research organization. He is the editor-in-chief of American Heart Journal, the oldest cardiovascular specialty journal.
Califf completed his undergraduate studies at Duke University in 1973, summa cum laude and Phi Beta Kappa, and later graduated from the Duke University Medical School. After completing his internship and internal medicine residency at the University of California, San Francisco, he returned to Duke for a fellowship in cardiology. He is board-certified in internal medicine and cardiology.
Considered an international leader in the fields of cardiovascular disease treatment, health outcomes, quality of care, and medical economics, Califf is the author or coauthor of more than 1,000 peer-reviewed articles. The Institute for Scientific Information acknowledges him as one of the 10 most-cited authors in the field of medicine. As director of DTMI, Califf’s contribution includes serving as the first co-chair of the Principal Investigators Steering Committee of the NIH Clinical and Translational Science Award.
As the founder and director of DCRI, Califf led many landmark clinical trials in cardiovascular disease. Under his leadership, DCRI grew to an organization of more than 1,000 employees with an annual budget of over $100 million. A leader in clinical research, DCRI collaborates with government agencies, global academic partners, foundations and biotech, pharmaceutical, device, and diagnostics companies to execute clinical trials in a myriad of therapeutic arenas.
Dr. Daniel Wilson, vice president for health affairs and dean of medicine at the University of Florida Health Science Center in Jacksonville
Campus Visit: June 19-21
Public Presentation: 4 p.m., June 20, Room 1002 of the Durham Research Center
Wilson has served at the University of Florida since 2012. Prior to that, he was chairman of psychiatry at Creighton University for 11 years, where he was also a professor of psychiatry, neurology and anthropology.
Wilson has a strong research track record, with more than 50 grants as principal investigator. While his primary focus is forensic psychiatry, Wilson’s research agenda ranges from pharmaceutical development to treatment of mood, psychosis and posttraumatic stress disorders.
Prior to his appointments at Creighton, Wilson served as a professor of psychiatry at the
University of Cincinnati, where he directed the University Institute for Medicine & Law. He also served as medical director of The Lewis Center of the Ohio Department of Mental Health, managing some 600 employees with a budget of $35 million. Under his leadership, the National Alliance on Mental Illness named the hospital the Best Psychiatric Facility in Ohio.
Wilson received his undergraduate degree in anthropology from Yale University, his medical degree from the University of Iowa and a diploma in mental health leadership from Case Western Reserve University. He completed residency in psychiatry as a joint appointee of Harvard Medical School and the Massachusetts General & McLean Hospitals.
By working at the intersection of the fields of medicine, psychiatry and anthropology, Wilson has created hundreds of scholarly articles on a wide cross-section of topics that have earned him worldwide recognition. He has penned more than 200 papers, books, chapters and other scientific communications across a range of subjects including psychiatric diagnosis, psychopharmacology, forensics and evolutionary medicine.
Campus Visit: June 3-5
Public Presentation: 4 p.m., June 4, Room 1002 of the Durham Research Center
Meyers oversees the research, teaching, clinical care and community engagement missions of UC Davis’ School of Medicine in coordination with leadership across the UC Davis community. Meyers also is the executive director of medical education and academic planning for the University of California, Merced, where he leads efforts to establish a school of medicine.
Meyers is a proponent of innovative research. He is a director of the Clinical and Translational Science Center’s Research and Education Career Development Program, as well as the Mentored Clinical Research Training Program. He continues research on cancer molecular biology and metastatic cancer, conducting numerous clinical trials on prostate cancer and gene expression in renal cell carcinoma.
Meyers is a longtime leader of the hospice and palliative care movement, establishing programs that are now national models for providing compassionate end-of-life care. He was founding director of the School of Medicine's West Coast Center for Palliative Care. He is also known for his work in “simultaneous care,” a model of care that allows cancer patients with advanced disease to receive both investigational treatments and palliative care.
A UC Davis faculty member since 1982, Meyers is an expert in hematology and oncology, with a special emphasis on the molecular biology of cancer and on clinical trials. His scholarly work includes more than 200 publications, book chapters, editorials and reviews.
Meyers obtained his medical degree from the UC San Francisco School of Medicine and completed his internship and residency training at UC Davis Medical Center.